DCT and melanoma: Firstly, the levels of established melanoma biomarkers, namely MIA, S100B, and tyrosinase-related protein 2 (TYRP2), were compared between exosomes isolated from the sera and total serum samples of stage IV melanoma patients and healthy controls.